Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Lowered 2025 guidance due to weak cosmetics demand and temporary softness in medical packaging, but organic growth is expected to bounce back driven by demand for injectable drug packaging.
— Krishna Mohanraj
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Gerresheimer
No other institutional pitches found for this ticker yet.
More institutional theses from Diamond Hill International
The manager purchased MAX Co., a Japanese manufacturer of pneumatic construction and manufacturing tools, citing its industry-leading Twintier rebar-tying products. The company features...
Dino Polska has successfully gained market share in a highly inflationary climate by maintaining strict price discipline, appealing to consumers trading down to discounters. Management has prudently...
Epiroc commands a leading position in the surface and underground drilling equipment space, supported by a highly profitable aftermarket services segment that mitigates cyclical risks. Operating within a...